Circulating Tumor Cells and Early Relapse in Node-positive Melanoma

Abstract

≥1 CTC was independently associated with melanoma relapse, suggesting that CTC assessment may be useful to identify patients at risk for relapse who could derive benefit from adjuvant therapy.